Heavyweight bout: Encyclopedia Britannica vs. Nature

Roll up for the public battering of the publishing heavyweights. In the red corner, from London, England, 'the world's top multidisciplinary science journal,' and in the blue corner, from Chicago, Illinois, 'the oldest continuously published reference work in the English language.' Ding! Ding! Round 1: Nature lands the opening blow with a linkurl:news article;http://www.nature.com/news/2005/051212/full/438900a.html on December 14 that compared the accuracy of science coverage from Encyclopaedi

Written byRichard Gallagher
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Roll up for the public battering of the publishing heavyweights. In the red corner, from London, England, 'the world's top multidisciplinary science journal,' and in the blue corner, from Chicago, Illinois, 'the oldest continuously published reference work in the English language.' Ding! Ding! Round 1: Nature lands the opening blow with a linkurl:news article;http://www.nature.com/news/2005/051212/full/438900a.html on December 14 that compared the accuracy of science coverage from Encyclopaedia Britannica and Wikipedia, concluding that that are 'numerous errors in both encyclopaedias, but ? the difference in accuracy was not particularly great.' Encyclopedia Britannica clearly hurt: chock full of errors and no better than a free upstart that anyone can write for? This was sufficiently interesting for us to linkurl:write about;http://www.the-scientist.com/article/display/23079/ . Round 2: Nature apparently stung, because a week after publication they provide linkurl:'supplementary information';http://www.nature.com/news/2005/051212/exref/supplementary_information.doc and admit that 'No test is perfect and we acknowledge that any of our reviewers could themselves have made occasional errors.' Round 3: EB puts together a linkurl:devastating combination;http://corporate.britannica.com/britannica_nature_response.pdf on March 22. The 20 pages can be summarized thus: 'Almost everything about the journal?s investigation, from the criteria for identifying inaccuracies to the discrepancy between the article text and its headline, was wrong and misleading.' Nature?s credibility hit hard here. EB claims that 'Contrary to the usual practice of making all data freely available in order to facilitate a study?s replication by others, Nature declined our repeated requests to make the full reports available.' Round 4: Nature comes off the ropes the next day. They put out a linkurl:press release;http://www.nature.com/press_releases/Britannica_response.pdf rejecting the EB accusation, stating that 'We ? are confident our comparison was fair' and characterizing the publication of the open letter by EB as a low blow. Down on points at the moment, Nature remains defiant. Or defiant-ish. Their missive closed with the strangely worded 'We do not intend to retract our article.' Round 5 is eagerly awaited. It could get bloody...
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies